
Fulgent Genetics FLGT
$ 15.01
0.6%
Quarterly report 2025-Q3
added 11-07-2025
Fulgent Genetics Operating Cycle 2011-2026 | FLGT
Annual Operating Cycle Fulgent Genetics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 77.4 | 65.5 | 56.5 | 59.4 | 82.4 | 87.9 | 117 | 93.2 | 109 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 117 | 56.5 | 83.2 |
Quarterly Operating Cycle Fulgent Genetics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 80.5 | 82.9 | 87.3 | - | 72.4 | 69.8 | 73 | - | 45.3 | 52.7 | 66.4 | - | 45 | 58.3 | 42.6 | 47.1 | 53.9 | 108 | 50.8 | 56.9 | 165 | 972 | 1.12 K | 71.3 | 57.8 | 71 | 106 | 95.7 | 96.5 | 101 | 97.6 | 85.4 | 81.2 | 78.8 | 72 | 68 | 79.5 | 100 | 86 | 66.6 | 33.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.12 K | 33.3 | 126 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M | ||
|
Castle Biosciences
CSTL
|
97.4 | $ 20.58 | -16.87 % | $ 597 M | ||
|
Burning Rock Biotech Limited
BNR
|
275 | $ 17.01 | - | $ 179 M | ||
|
Agilent Technologies
A
|
161 | $ 118.71 | 0.87 % | $ 36.1 B | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 427.53 | 0.17 % | $ 12.3 B | ||
|
Myriad Genetics
MYGN
|
95.1 | $ 4.13 | 0.36 % | $ 382 M | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
NeoGenomics
NEO
|
102 | $ 9.09 | 2.25 % | $ 1.16 B | ||
|
National Research Corporation
NRC
|
29.4 | $ 17.74 | -0.67 % | $ 397 M | ||
|
Natera
NTRA
|
81.5 | $ 216.41 | 0.61 % | $ 21.3 B | ||
|
Aspira Women's Health
AWH
|
1.2 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 27.67 | 1.62 % | $ 26.2 B | ||
|
Personalis
PSNL
|
55.8 | $ 6.09 | 0.25 % | $ 361 M | ||
|
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 21.84 | 4.25 % | $ 1.16 B | ||
|
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | ||
|
Soleno Therapeutics
SLNO
|
1.04 K | $ 52.94 | -0.01 % | $ 2.69 B | ||
|
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | ||
|
Co-Diagnostics
CODX
|
1.79 K | $ 1.73 | 5.45 % | $ 2.3 M | ||
|
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | ||
|
Trinity Biotech plc
TRIB
|
299 | $ 0.61 | 0.53 % | $ 219 M | ||
|
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | ||
|
Twist Bioscience Corporation
TWST
|
96.1 | $ 58.99 | -0.91 % | $ 3.53 B | ||
|
Charles River Laboratories International
CRL
|
65 | $ 184.27 | 1.4 % | $ 9.13 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
91.7 | - | - | $ 19.8 B | ||
|
Guardant Health
GH
|
128 | $ 90.55 | -1.84 % | $ 11.4 B | ||
|
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 124.9 | 0.62 % | $ 10.3 B | ||
|
Illumina
ILMN
|
198 | $ 139.88 | -1.89 % | $ 22.2 B | ||
|
Senseonics Holdings
SENS
|
104 | $ 5.32 | -0.84 % | $ 222 M | ||
|
Interpace Biosciences
IDXG
|
96 | $ 2.04 | -3.33 % | $ 9.02 M | ||
|
Waters Corporation
WAT
|
834 | $ 346.81 | -0.86 % | $ 20.7 B | ||
|
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
204 | $ 2.17 | -1.84 % | $ 4.98 M | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 473.95 | 0.12 % | $ 179 B | ||
|
Lantheus Holdings
LNTH
|
121 | $ 89.06 | 3.38 % | $ 6.01 B | ||
|
Laboratory Corporation of America Holdings
LH
|
71.8 | $ 256.98 | 0.02 % | $ 21.4 B | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
213 | $ 9.15 | -0.33 % | $ 1.98 B | ||
|
Quest Diagnostics Incorporated
DGX
|
54.2 | $ 189.75 | 0.33 % | $ 21.1 B |